BEUDAMED
    FDA Adverse Event Injury Summary report: N

    10MM TI CANNULATED TIBIAL NAIL-EX/345MM-STERILE

    MDR report key: 8480434 · Received April 3, 2019

    Report

    Report Number
    2939274-2019-57261
    Event Type
    Injury
    Date Received
    April 3, 2019
    Report Date
    March 11, 2019
    Manufacturer
    WRIGHTS LANE SYNTHES USA PRODUCTS LLC
    Product Code
    JDS
    UDI-DI
    10886982084217
    PMA / PMN Number
    K040762
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    IL, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL

    Narratives

    Additional Manufacturer Narrative · 0

    DEPUY SYNTHES IS SUBMITTING THIS REPORT PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT MAY BE BASED ON INFORMATION WHICH DEPUY SYNTHES HAS NOT BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE REQUIRED REPORTING DATE. THIS REPORT DOES NOT REFLECT A CONCLUSION BY FDA, DEPUY SYNTHES OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, DEPUY SYNTHES, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE POTENTIAL EVENT DESCRIBED IN THIS REPORT. DEVICE HISTORY LOT: MANUFACTURING LOCATION: MONUMENT, MANUFACTURING DATE: 09-SEP-2016, EXPIRATION DATE: 31-AUG-2025, PART NUMBER: 04.004.449S, - 10MM TI CANNULATED TIBIAL NAIL - EX/345M ¿ STERILE, LOT NUMBER: H182991 (STERILE), LOT QUANTITY: (B)(4). WORK ORDER TRAVELER MET ALL INSPECTION ACCEPTANCE CRITERIA. INSPECTION SHEET, IN-PROCESS ACCEPTANCE SHEET, MET ALL INSPECTION ACCEPTANCE CRITERIA. INSPECTION SHEET, INSPECT DIMENSIONAL MET ALL INSPECTION ACCEPTANCE CRITERIA. INSPECTION SHEET, FINAL INSPECTION, MET ALL INSPECTION ACCEPTANCE CRITERIA. PACKAGING LABEL LOG WAS REVIEWED AND DETERMINED TO BE CONFORMING. PACKAGING BOM WAS REVIEWED AND DETERMINED TO BE CONFORMING WITH NO DEVIATIONS TO NORMAL PACKAGING IDENTIFIED. SCN 12950 SUPPLIED BY ETHICON (ABQ) WAS REVIEWED AND DETERMINED TO BE CONFORMING. THIS LOT MET ALL DIMENSIONAL, VISUAL, STERILITY AND PACKAGING CRITERIA AT THE TIME OF RELEASE WITH NO ISSUES DOCUMENTED DURING THE MANUFACTURE THAT WOULD CONTRIBUTE TO THIS COMPLAINT CONDITION. COMPONENT PART(S) REVIEWED: RAW MATERIAL WAS NOT REVIEWED BECAUSE THE REPORTED COMPLAINT CONDITION OF ¿REMOVAL DUE TO NON-UNION¿ DOES NOT INDICATE BREAKAGE OF THE NAIL OR ANY OF ITS COMPONENTS. THEREFORE, A DHR REVIEW OF THE RAW MATERIAL WOULD NOT BE PERTINENT TO THE REPORTED COMPLAINT CONDITION. DEVICE HISTORY BATCH NULL, DEVICE HISTORY REVIEW 18-MAR-2019: DHR REVIEWED. THIS LOT MET ALL DIMENSIONAL, VISUAL, STERILITY AND PACKAGING CRITERIA AT THE TIME OF RELEASE WITH NO ISSUES DOCUMENTED DURING THE MANUFACTURE THAT WOULD CONTRIBUTE TO THIS COMPLAINT CONDITION. IT WAS REPORTED THAT ON AN UNKNOWN DATE, THE PATIENT WENT TO THE DOCTOR'S OFFICE WITH LEG PAIN. CT SCAN WAS PERFORMED AND DESPITE SIGNIFICANT CALLUS FORMATION, THERE WAS A NON-UNION PRESENT. ON AN UNKNOWN DATE, THE PATIENT UNDERWENT REMOVAL OF TITANIUM CANNULATED TIBIAL NAIL, UNKNOWN END CAP, AND UNKNOWN LOCKING SCREWS. IN 2018, THE HARDWARE WAS ORIGINALLY IMPLANTED DUE TO SUSTAINED FRACTURE OF THE LEFT TIBIA. THE NON-UNION WAS REVISED BY IMPLANTING A NEW LARGER DIAMETER TIBIA NAIL. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT HARM OR DELAY. THE IMPLANT(S) WAS NOT RETURNED AND INSTEAD WILL BE DO BASED ON THE SUPPLIED IMAGE FROM THE ATTACHMENT(S) LABELED: (B)(4) INTAKE EMAIL RECEIVED FROM SALES CONSULTANT 12MAR2019. THE IMAGE(S) (2 TOTAL) WAS REVIEWED AND THE COMPLAINT CONDITION FOR ADVERSE EVENT COULD NOT BE CONFIRMED AS NO CONCLUSIONS COULD BE DRAWN FROM THE IMAGE(S) PROVIDED. AS THE IMPLANT WAS NOT RETURNED AN AS RECEIVED, DIMENSIONAL, MATERIAL OR DRAWING REVIEWS ARE NOT APPLICABLE. A DEVICE HISTORY REVIEW, WAS PERFORMED FOR THE RETURNED INSTRUMENT¿S LOT NUMBER, AND NO NCRS, NO MRRS OR COMPLAINT-RELATED ISSUES WERE IDENTIFIED WITH THE LOT NUMBER WHICH MAY HAVE CONTRIBUTED TO THE COMPLAINT CONDITION. NO DEFINITIVE ROOT CAUSE WAS ABLE TO BE DETERMINED AS THE CIRCUMSTANCES SURROUNDING THE EVENT ARE UNKNOWN. DURING THE INVESTIGATION NO UNIDENTIFIED PRODUCT DESIGN/MANUFACTURING ISSUES OR DISCREPANCIES WERE OBSERVED (BASED ON THE IMAGES) THAT MAY HAVE CONTRIBUTED TO THE COMPLAINT CONDITION. ADDITIONAL MONITORING FOR ANY POTENTIAL SAFETY SIGNALS WILL BE CONDUCTED THROUGH COMPLAINT TRENDING AND OTHER POST MARKET SAFETY SURVEILLANCE ACTIVITIES. BASED ON THE INVESTIGATION FINDINGS, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND/OR PREVENTATIVE ACTION IS PROPOSED. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

    Additional Manufacturer Narrative · 1

    COMPLAINANT PART IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. (B)(4). A REVIEW OF THE DEVICE HISTORY RECORDS HAS BEEN REQUESTED. THE INVESTIGATION COULD NOT BE COMPLETED; NO CONCLUSION COULD BE DRAWN, AS NO PRODUCT WAS RECEIVED. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

    Description of Event or Problem · 1

    IT WAS REPORTED THAT ON AN UNKNOWN DATE, THE PATIENT WENT TO THE DOCTOR'S OFFICE WITH LEG PAIN. CT SCAN WAS PERFORMED AND DESPITE SIGNIFICANT CALLOUS FORMATION, THERE WAS A NON-UNION PRESENT. ON (B)(6) 2019, THE PATIENT UNDERWENT REMOVAL OF TITANIUM CANNULATED TIBIAL NAIL, UNKNOWN END CAP, AND UNKNOWN LOCKING SCREWS. IN 2018, THE HARDWARE WAS ORIGINALLY IMPLANTED DUE TO SUSTAINED FRACTURE OF THE LEFT TIBIA. THE NON-UNION WAS REVISED BY IMPLANTING A NEW LARGER DIAMETER TIBIA NAIL. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITHOUT HARM OR DELAY. THIS COMPLAINT INVOLVES THREE (3) DEVICES. THIS REPORT IS FOR ONE (1) 10MM TI CANNULATED TIBIAL NAIL-EX/345MM-STERILE. THIS REPORT IS 1 OF 3 FOR (B)(4).

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    271057 10MM TI CANNULATED TIBIAL NAIL-EX/345MM-STERILE NAIL,FIXATION,BONE JDS WRIGHTS LANE SYNTHES USA PRODUCTS LLC 04.004.449S H182991 10886982084217

    Patients

    Seq Age Sex Outcome Treatment
    1 Required Intervention